MiMedx Merger with Sanara MedTech Delayed by FTC's Second Antitrust Request

MiMedx Group, Inc. announced that it and Sanara MedTech Inc. have received a request for additional information (a "Second Request") from the Federal Trade Commission (FTC) regarding their previously announced merger. This request extends the regulatory review period, delaying the closing of the transaction.

Key Details

• Event Date: The Second Request was received on October 15, 2026.
• Regulatory Impact: The request extends the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act until 30 days after both companies have substantially complied with the FTC's request.
• Transaction Status: The merger's completion remains subject to the termination of the HSR waiting period and other customary closing conditions. The company stated it is working constructively with the FTC.